Solvay Pharmaceuticals Asia
>
Services
>
Members
Other Solvay Sites
------------------------------------------------
Solvay.com
---------- Business Portals ----------
PHARMACEUTICALS PORTAL
Aceon
Androgel
Depression Center
Duodopa
Duphalac
Duphalac Italy
Influenza Center
Irritable Bowel Syndrome
Lactulose
Marinol
Menopause Center
Moses Study
Solvay Arzneimmittel
Solvay Healthcare
Solvay Injectables
Solvay Omacor
Solvay Pharma Belgium
Solvay Pharma Canada
Solvay Pharma Espana
Solvay Pharma Schweiz
Solvay Pharmaceuticals - AMAC
Solvay Pharmaceuticals NL
Solvay Pharmaceuticals US
Teveten
CHEMICALS PORTAL
PLASTICS PORTAL
> Other sites by Businesses
----------- Country Portals -----------
Solvay Austria
Solvay China
Solvay Deutschland
Solvay France
Solvay Iberica
Solvay Italia
Solvay Nordic
Solvay North America
Solvay Portugal
Solvay Schweiz
> Other sites by Regions
This Site
All Sites
Home
About Solvay
Ernest Solvay
History
Product evolution
Organization
R&D
Four therapeutic areas
New medicines
Tedisamil (PULZIUM®) in atrial flutter and fibrillation
Research in obesity
IBS and cilansetron
Research in pancreatic enzymes
Research in Mental Health - Bifeprunox
Research in Parkinson's disease
Research in influenza prevention
Research in women's health
R&D Process
The pipeline
Scientific collaborations
Products
Cardiometabolics
Omacor®
Teveten®
Tricor/Lipanthyl®
Gastroenterology
Dicetel®
Duphalac®
Duspatal®
Influenza vaccines
Influvac®
Neuroscience
bifeprunox
Duodopa®
Luvox®
Serc®
Pancreatic enzymes
Creon®
Women's and men's health
AndroGel®
Duphaston®
Femoston®
Contact us
Links
News
Regional Management
Canada
Asia Pacific
Australia
China
Hong Kong
Korea North
Korea South
New Zealand
Taiwan
Middle East
Bahrain
Egypt
Iran
Iraq
Israel
Jordan
Kuwait
Lebanon
Oman
Palestine
Qatar
Saudi Arabia
Syria
Turkey
United Arab Emirates
Yemen
South East Asia
Bangladesh
Cambodia
India
Indonesia
Malaysia
Pakistan
Philippines
Singapore
Sri Lanka
Thailand
Vietnam
Members
Members
© Solvay S.A • Important information :
Privacy policy
-
Disclaimer
• If you have any comments, please contact the
webmaster
Date of last update: 7/6/2008
